Court deems RevitaLash eyelash conditioner to be a drug

Published: 20-Jul-2012
Regulatory

Athena Cosmetics disagrees with the ruling


A district court in California has ruled that Athena Cosmetics’ RevitaLash Advanced Eyelash Conditioner is a drug and not a cosmetic. The decision was made by the district court judge in a civil lawsuit filed by Allergan, manufacturer of Latisse, a prescription treatment for eyelash hypotrichosis. As a drug, the product will need to have FDA approval before it can be sold.

Athena said it disagreed with the ruling and intended to “vigorously pursue its legal options”.

It added: “Despite the Court’s ruling, Athena is confident that all RevitaLash products are safe and lawful cosmetics. However, out of an abundance of caution, Athena has suspended domestic sales of RevitaLash Advanced Eyelash Conditioner until further notice. All other RevitaLash products remain available for purchase.”

Allergan is currently the only FDA-approved manufacturer of a prostaglandin product for the stimulation of hair growth in the US. The case has been ongoing since 2007 when Allergan filed a suit against Athena Cosmetics and a number of other companies, alleging that they had infringed its patented treatment for eyelash growth and violated California’s unfair competition laws.

  • Companies:
  • Allergan
  • Cosmeceuticals
See more

You may also like

Regulatory

Linda Evangelista blames CoolSculpting nightmare on commercials shown ‘over and over’

Read more
In a British Vogue interview, the supermodel confessed to liking the concept of no downtime or surgery; but what does excessive promotion of treatments mean for vulnerable consumers?

Trending Articles

  1. Charlotte Tilbury setting spray withdrawal hits Puig shares The Barcelona-based conglomerate is the latest company to voluntarily withdraw product batches for quality issues
  2. Registrar Corp Acquires Personal Care Regulatory (PCR), Expanding Global Cosmetic Regulatory Compliance Services Registrar Corp, the world's largest cosmetics compliance company, is pleased to announce its acquisition of Personal Care Regulatory (PCR) Group, a leading cosmetic regulatory, toxicology, and compliance company based in the United Kingdom (UK) and Ireland. This strategic acquisition extend Registrar’s global regulatory compliance capabilities
  3. Drunk Elephant initiates voluntary product recall in the US The skin care brand said there was an isolated ingredient mix-up between preservatives and surfactants during production
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    A complete guide to the EU’s new retinol laws Iona Silverman from law firm Freeths explains the European Union’s clampdown on retinol in cosmetics, covering the changes, timelines and exempt ingredients
  5. Boots TV advert banned by ASA for ‘flippant’ sun safety remarks The Boots’ No7 Future Renew serum advert featured women reminiscing about being “too busy having fun” to wear sunscreen

Upcoming event

Launch Lab: Future-Forward Cosmetics – Beyond Packaging 2025 - WEBINAR

17 January 2025 See all

You may also like

Regulatory

Linda Evangelista blames CoolSculpting nightmare on commercials shown ‘over and over’

In a British Vogue interview, the supermodel confessed to liking the concept of no downtime or surgery; but what does excessive promotion of treatments mean for vulnerable consumers?
Regulatory

Linda Evangelista says she has been 'brutally disfigured' by cosmetic treatment

The Canadian supermodel rose to fame in the 1990s, but claims her career is now on hold due to Allergan's CoolSculpting fat freezing procedure
Regulatory

Botox battle: Allergan attempts to block sale of injectables competitor in US market with support of ITC

The US’ International Trade Commission agreed that Daewoong’s rival product, Jeuveau, was unfairly sold in the US market, however, the full details of the decision have not yet been disclosed
Regulatory

Registrar Corp Acquires Personal Care Regulatory (PCR), Expanding Global Cosmetic Regulatory Compliance Services

Registrar Corp, the world's largest cosmetics compliance company, is pleased to announce its acquisition of Personal Care Regulatory (PCR) Group, a leading cosmetic regulatory, toxicology, and compliance company based in the United Kingdom (UK) and Ireland. This strategic acquisition extend Registrar’s global regulatory compliance capabilities
Regulatory

Charlotte Tilbury setting spray withdrawal hits Puig shares

The Barcelona-based conglomerate is the latest company to voluntarily withdraw product batches for quality issues
Regulatory

US recalls 13,000 candles due to fire and laceration hazards

Seven instances of high flames associated with Vacation’s Legendary Vacation sku were reported
Regulatory

CTPA manifesto argues beauty be considered a sub-sector of life sciences

The UK’s representative body for the cosmetics industry unveiled its ‘Agenda for Government’ at a parliamentary reception
Subscribe now